M Evo Global II Targets Critical Minerals in $225M SPAC IPO

TL;DR

**MEVOU is a high-risk SPAC play on critical minerals, but watch out for massive founder dilution and misaligned incentives from the $0.003 per share cost.**

AI Summary

M Evo Global Acquisition Corp II (MEVOU) filed an S-1 for an initial public offering of 22,500,000 units at $10.00 per unit, aiming to raise $225,000,000. Each unit comprises one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable at $11.50. The SPAC intends to target companies in the critical minerals sector, crucial for U.S. economic and national security. Underwriting discounts and commissions total $13,500,000, with $9,000,000 deferred and contingent on business combination completion. The sponsor, Evolution Sponsor Holdings LLC II, and management hold 8,333,333 Class B ordinary shares purchased for $25,000, or approximately $0.003 per share, which will convert to Class A shares. Additionally, the sponsor and underwriters will purchase 6,500,000 private placement warrants for $6,500,000. The company has 24 months from the offering's close to complete a business combination, with a monthly payment of $15,000 to the sponsor for administrative services.

Why It Matters

This S-1 filing signals M Evo Global Acquisition Corp II's entry into the SPAC market, specifically targeting the critical minerals sector, which is strategically important for national security and economic resilience. Investors should note the significant founder share ownership at a nominal cost of $0.003 per share, creating potential dilution and misaligned incentives compared to public shareholders. The 24-month timeline for a business combination puts pressure on management to find a suitable target, while the deferred underwriting fees of up to $9,000,000 incentivize deal completion, potentially at the expense of optimal terms. The focus on critical minerals could attract investors seeking exposure to this vital industry, but the inherent risks of SPACs, including the lack of a specific target, remain high.

Risk Assessment

Risk Level: high — The risk level is high due to the blank check nature of the company, with no selected business combination target. Significant dilution risk exists from the 8,333,333 Class B ordinary shares held by the sponsor and management, purchased at approximately $0.003 per share, compared to the public offering price of $10.00 per unit. Additionally, the deferred underwriting commission of up to $9,000,000, payable only upon completion of a business combination, creates an incentive for underwriters to push for a deal regardless of its quality.

Analyst Insight

Investors should approach MEVOU with extreme caution, recognizing the significant dilution potential from founder shares and the inherent risks of a blank check company. Consider waiting until a definitive business combination target is announced and thoroughly evaluate the terms of any proposed merger before investing. The focus on critical minerals offers a thematic play, but the SPAC structure introduces substantial additional risk.

Financial Highlights

debt To Equity

N/A

revenue

N/A

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

N/A

eps

N/A

gross Margin

N/A

cash Position

$211,500,000

revenue Growth

N/A

Key Numbers

• $225,000,000 — Total Public Offering Price (Amount to be raised from the IPO of 22,500,000 units at $10.00 each.)
• 22,500,000 — Units Offered (Number of units being offered in the initial public offering.)
• $10.00 — Per Unit Offering Price (Price at which each unit is offered to the public.)
• $13,500,000 — Underwriting Discounts and Commissions (Total fees payable to underwriters, including $9,000,000 deferred.)
• $0.003 — Founder Share Purchase Price (Approximate per-share price paid by the sponsor for Class B ordinary shares.)
• 8,333,333 — Class B Ordinary Shares (Number of founder shares held by the sponsor and management.)
• 6,500,000 — Private Placement Warrants (Number of warrants purchased by the sponsor and underwriters in a private placement.)
• $1.00 — Private Placement Warrant Price (Price per warrant in the private placement.)
• 24 months — Business Combination Deadline (Timeframe to complete an initial business combination from the closing of the offering.)
• $15,000 — Monthly Sponsor Payment (Amount paid monthly to the sponsor for administrative services for the first 15 months.)

Key Players & Entities

• M Evo Global Acquisition Corp II (company) — Registrant for S-1 filing
• Stephen Silver (person) — Chief Executive Officer and Chairman of the Board
• Ashley Zumwalt-Forbes (person) — Chief Operating Officer and Director
• Arthur Chen (person) — Chief Financial Officer
• Evolution Sponsor Holdings LLC II (company) — Sponsor of the SPAC
• U.S. Securities and Exchange Commission (regulator) — Filing authority
• Loeb & Loeb LLP (company) — Legal counsel
• Greenberg Traurig, LLP (company) — Legal counsel
• Continental Stock Transfer and Trust Company (company) — Trustee and transfer agent
• Cohen & Company Capital Markets (company) — Representative of the underwriters

FAQ

Risk Factors

• Redemption Risk [high — financial]: A significant portion of the IPO proceeds ($225,000,000) will be placed in a trust account, subject to shareholder redemption rights. If a substantial number of shareholders redeem their shares, the SPAC may not have sufficient capital to complete its intended business combination, especially if the target company requires a significant investment.
• Target Industry Volatility [high — market]: The SPAC targets companies in the critical minerals sector, which is subject to significant price volatility, geopolitical risks, and supply chain disruptions. These factors can impact the valuation and operational stability of potential acquisition targets.
• Business Combination Timeline [high — operational]: The SPAC has a strict 24-month deadline to complete a business combination. Failure to do so will result in liquidation, potentially leading to a loss for investors who do not redeem their shares.
• Sponsor Dilution and Alignment [medium — financial]: The sponsor acquired 8,333,333 Class B shares for $25,000 (approximately $0.003 per share), which will convert to Class A shares. This significant discount to the public offering price of $10.00 per unit creates potential for substantial dilution for public shareholders and raises questions about alignment of interests.
• Underwriting and Deferred Commissions [medium — financial]: Underwriting discounts and commissions total $13,500,000, with $9,000,000 deferred and contingent on business combination completion. This deferred amount represents a significant cost that will reduce the net proceeds available for the business combination if it occurs.
• Lack of Operating History [medium — regulatory]: As a newly formed blank check company, M Evo Global Acquisition Corp II has no operating history or established business. This lack of track record makes it difficult to assess its future performance and the viability of its management's strategy.
• Private Placement Warrants [low — financial]: The sponsor and underwriters are purchasing 6,500,000 private placement warrants for $6,500,000 ($1.00 per warrant). These warrants, if exercised, will dilute public shareholders and represent an additional cost to the SPAC.
• Sponsor Administrative Fees [low — operational]: The SPAC will pay its sponsor $15,000 per month for administrative services for the first 15 months. While seemingly small, these fees represent an ongoing cost that reduces capital available for the business combination.

Industry Context

M Evo Global Acquisition Corp II is targeting the critical minerals sector, a field vital for U.S. economic and national security. This sector is characterized by high demand driven by technological advancements and the global energy transition, but also faces significant volatility due to geopolitical factors, supply chain dependencies, and commodity price fluctuations. The competitive landscape includes established mining companies, other resource-focused SPACs, and private equity firms actively seeking opportunities in this space.

Regulatory Implications

As a Cayman Islands exempted company, M Evo Global Acquisition Corp II is subject to U.S. securities laws due to its SEC registration and listing plans. The critical minerals sector itself may face increasing regulatory scrutiny related to environmental, social, and governance (ESG) standards, as well as national security concerns regarding supply chain diversification and foreign ownership. Compliance with these evolving regulations will be crucial for any target company.

What Investors Should Do

1. Evaluate the critical minerals target carefully.
2. Understand redemption rights and potential dilution.
3. Monitor the 24-month business combination deadline.
4. Assess the sponsor's track record and alignment.

Key Dates

• 2025-12-15: Filing of S-1 Registration Statement — Marks the initial public filing for the SPAC's IPO, providing details on its structure, offering, and intended business combination strategy.
• 2025-12-15: Proposed IPO Date — Indicates the earliest practicable date for the commencement of the proposed sale of securities to the public.
• 2027-12-15: Business Combination Deadline — The SPAC has 24 months from the closing of the IPO to complete a business combination, after which it will liquidate if unsuccessful.

Glossary

SPAC

Special Purpose Acquisition Company. A shell company that is formed to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company. (M Evo Global Acquisition Corp II is a SPAC.)

Unit

A security that combines multiple types of securities, typically a share of common stock and a warrant, offered together in an IPO. (The IPO consists of units, each containing one Class A ordinary share and one-third of a redeemable warrant.)

Redeemable Warrant

A warrant that gives the holder the right, but not the obligation, to purchase a share of common stock at a specified price within a certain timeframe. These are often redeemable by the issuer under specific conditions. (Each unit includes a redeemable warrant, exercisable at $11.50, and subject to redemption by the SPAC.)

Class B Ordinary Shares

Shares typically held by the SPAC's sponsor and management, often with different voting rights or conversion features compared to Class A shares. These are usually converted to Class A shares upon a business combination. (The sponsor holds 8,333,333 Class B ordinary shares that will convert to Class A shares.)

Trust Account

A segregated account where the proceeds from a SPAC's IPO are held in trust, typically invested in U.S. Treasury securities, until a business combination is completed or the SPAC liquidates. ($225,000,000 of the IPO proceeds will be placed in a trust account.)

Business Combination

The merger, acquisition, or other transaction through which a SPAC combines with an operating company. (The primary objective of the SPAC is to identify and complete a business combination within 24 months.)

Deferred Underwriting Commissions

A portion of the underwriting fees that is not paid at the closing of the IPO but is instead held in escrow and paid to the underwriters only upon the successful completion of a business combination. ($9,000,000 of the underwriting commissions are deferred.)

Critical Minerals

Minerals and metals that are essential for the economic and national security of a country, often used in advanced technologies and defense applications. (The SPAC intends to target companies in this sector for its business combination.)

Year-Over-Year Comparison

This is an initial S-1 filing for M Evo Global Acquisition Corp II, meaning there is no prior year filing to compare against. As a newly formed SPAC, it has no historical financial performance, revenue, or operational metrics. All financial data presented pertains to the proposed offering structure and the intended use of proceeds, rather than historical business operations.

Key Financial Figures

• $225,000,000 M — O COMPLETION, DATED DECEMBER 15, 2025 $225,000,000 M Evo Global Acquisition Corp II 22,500
• $10.00 — ies. Each unit has an offering price of $10.00 and consists of one Class A ordinary sh
• $11.50 — ne Class A ordinary share at a price of $11.50 per share, subject to adjustment as des
• $0.20 — 500,000 ____________ (1) Includes (a) $0.20 per unit sold in the offering, or $4,50
• $4,500,000 — $0.20 per unit sold in the offering, or $4,500,000 in the aggregate (or $5,000,000 if the
• $5,000,000 — ing, or $4,500,000 in the aggregate (or $5,000,000 if the underwriters' over -allotment op
• $675,000 — is exercised in full, which includes a $675,000 cash reimbursement for offering expense
• $750,000 — reimbursement for offering expenses, or $750,000 if the underwriters' over -allotment op
• $0.10 — closing of this offering, of which (i) $0.10 per unit will be paid to the underwrite
• $0.40 — ase private placement warrants; and (b) $0.40 per unit sold in the offering, or up to
• $9,000,000 — per unit sold in the offering, or up to $9,000,000 in the aggregate (or up to $10,000,000
• $10,000,000 — o $9,000,000 in the aggregate (or up to $10,000,000 in the aggregate if the over -allotment
• $225,000,000 — warrants described in this prospectus, $225,000,000, or $250,000,000 if the underwriters' o
• $250,000,000 — ed in this prospectus, $225,000,000, or $250,000,000 if the underwriters' over -allotment op
• $25,000 — nsor for an aggregate purchase price of $25,000, or approximately $0.003 per share. The

Filing Documents

• ea0257707-02.htm (S-1) — 4355KB
• ea025770702ex1-1_mevo2.htm (EX-1.1) — 247KB
• ea025770702ex3-1_mevo2.htm (EX-3.1) — 218KB
• ea025770702ex3-2_mevo2.htm (EX-3.2) — 279KB
• ea025770702ex4-1_mevo2.htm (EX-4.1) — 18KB
• ea025770702ex4-2_mevo2.htm (EX-4.2) — 16KB
• ea025770702ex4-4_mevo2.htm (EX-4.4) — 141KB
• ea025770702ex5-1_mevo2.htm (EX-5.1) — 36KB
• ea025770702ex5-2_mevo2.htm (EX-5.2) — 9KB
• ea025770702ex10-1_mevo2.htm (EX-10.1) — 44KB
• ea025770702ex10-2_mevo2.htm (EX-10.2) — 51KB
• ea025770702ex10-3_mevo2.htm (EX-10.3) — 117KB
• ea025770702ex10-4_mevo2.htm (EX-10.4) — 40KB
• ea025770702ex10-5_mevo2.htm (EX-10.5) — 48KB
• ea025770702ex10-6_mevo2.htm (EX-10.6) — 115KB
• ea025770702ex10-7_mevo2.htm (EX-10.7) — 21KB
• ea025770702ex10-8_mevo2.htm (EX-10.8) — 49KB
• ea025770702ex10-9_mevo2.htm (EX-10.9) — 18KB
• ea025770702ex10-10_mevo2.htm (EX-10.10) — 12KB
• ea025770702ex14-1_mevo2.htm (EX-14.1) — 54KB
• ea025770702ex23-1_mevo2.htm (EX-23.1) — 2KB
• ea025770702ex99-1_mevo2.htm (EX-99.1) — 2KB
• ea025770702ex99-2_mevo2.htm (EX-99.2) — 2KB
• ea025770702ex99-3_mevo2.htm (EX-99.3) — 2KB
• ea025770702ex99-4_mevo2.htm (EX-99.4) — 42KB
• ea025770702ex99-5_mevo2.htm (EX-99.5) — 33KB
• ea025770702ex-fee_mevo2.htm (EX-FILING FEES) — 22KB
• ex5-2_001.jpg (GRAPHIC) — 10KB
• 0001213900-25-121608.txt ( ) — 9693KB
• ck0002087361-20251215.xsd (EX-101.SCH) — 9KB
• ck0002087361-20251215_def.xml (EX-101.DEF) — 15KB
• ck0002087361-20251215_lab.xml (EX-101.LAB) — 112KB
• ck0002087361-20251215_pre.xml (EX-101.PRE) — 68KB
• ea0257707-02_htm.xml (XML) — 1078KB
• ea025770702ex-fee_mevo2_htm.xml (XML) — 10KB

From the Filing

Filed with the U.S. Securities and Exchange Commission on December 15, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ––––––––––––––––––––––––––––––––––––––– FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ––––––––––––––––––––––––––––––––––––––– M Evo Global Acquisition Corp II (Exact name of registrant as specified in its charter) ––––––––––––––––––––––––––––––––––––––– Cayman Islands 6770 N/A (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 2727 LBJ Freeway Suite 1010 Farmers Branch, TX 75234 Tel: (214) 775-0614 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) ––––––––––––––––––––––––––––––––––––––– Stephen Silver Chief Executive Officer 2727 LBJ Freeway Suite 1010 Farmers Branch, TX 75234 Tel: (214) 775 -0614 (Name, address, including zip code, and telephone number, including area code, of agent for service) ––––––––––––––––––––––––––––––––––––––– Copies to : Mitchell S. Nussbaum, Esq. David J. Levine, Esq. Julia Aryeh, Esq. Loeb & Loeb LLP 345 Park Avenue New York, New York 10154 Tel: (212) 407-4000 Matthew Roberts, Esq. Maples and Calder (Hong Kong) LLP 26 th Floor, Central Plaza 18 Harbour Road, Wanchai, Hong Kong Tel: +852 2522 9333 Alan I. Annex, Esq. Jason T. Simon, Esq. Tricia Branker, Esq. Adam S. Namoury, Esq. Greenberg Traurig, LLP 1750 Tysons Boulevard, Suite 1000 McLean, Virginia 22102 Tel: (703) 749 -1300 ––––––––––––––––––––––––––––––––––––––– Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the U.S. Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine. Table of Contents The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. PRELIMINARY PROSPECTUS $225,000,000 M Evo Global Acquisition Corp II 22,500,000 Units ––––––––––––––––––––––––––––––––––––––– M Evo Global Acquisition Corp II is a blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initi

View Full Filing

View this S-1 filing on SEC EDGAR